PUMA BIOTECHNOLOGY, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2025
Total Assets: $216.3M
Liabilities Breakdown FY2025
Total Liabilities: $86.0M
Asset Breakdown
Total Assets: $216.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $29.6M | 13.7% |
| Accounts Receivable | $53.7M | 24.8% |
| Inventory | $5.5M | 2.5% |
| Property, Plant & Equipment | $187.0K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $41.4M | 19.1% |
| Other Assets | $85.9M | 39.7% |
Liabilities Breakdown
Total Liabilities: $86.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.1M | 5.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $80.9M | 94.1% |